Ricin Toxoid for Prophylactic Vaccine Trials from Germany
Detoxified ricin toxoid used in phase I/II vaccine trials for inducing immunity against ricin exposure. Fits HTS 3002.49.0010 as a toxin for prophylactic uses in clinical settings. Developed for military and civilian biodefense.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit IND application details and trial protocol to justify prophylactic classification
• Use validated cold chain with data loggers; pitfall is thermal excursion claims denial
• Declare as 'clinical trial toxin' to differentiate from research grade